Search results
Results From The WOW.Com Content Network
Vaping exposes non-users to particulate matter with a diameter of 2.5 μm, which poses health risks to non-users. [88] E-cigarettes produce propylene glycol aerosols at levels known to cause eye and respiratory irritation to non-users. [142] A 2014 study demonstrated that non-smokers living with vaping device users were exposed to nicotine. [143]
Vaping-associated pulmonary injury (VAPI), [4] also known as vaping-associated lung injury (VALI) [1] or e-cigarette, or vaping, product use associated lung injury (E/VALI), [2] [a] is an umbrella term, [15] [16] used to describe lung diseases associated with the use of vaping products that can be severe and life-threatening. [3]
You could notice your weight change within your first few weeks of weight loss treatment. But significant weight loss will generally take longer. A Novo Nordisk-funded 2021 study looked at almost ...
It's another reason to stop vaping in the new year. According to research, vaping, like smoking, has an immediate negative effect on the user’s blood flow — even if the vape does not contain ...
Based on reports from several states, patients have experienced respiratory symptoms (cough, shortness of breath, or chest pain), while some have also experienced gastrointestinal symptoms (nausea, vomiting, or diarrhea) or non-specific symptoms (fatigue, fever, or weight loss). [2] Some cases reported mild to moderate gastrointestinal illness ...
A new study indicates that people who have used a vape at any point in their lives are 19% more likely to experience heart failure compared to people who have never used them.
The LD 50 of nicotine is 50 mg/kg for rats and 3 mg/kg for mice. 0.5–1.0 mg/kg can be a lethal dosage for adult humans, and 0.1 mg/kg for children. [19] [20] However the widely used human LD 50 estimate of 0.5–1.0 mg/kg was questioned in a 2013 review, in light of several documented cases of humans surviving much higher doses; the 2013 review suggests that the lower limit causing fatal ...
First approved by the Food and Drug Administration (FDA) in 2017 to treat Type 2 diabetes, Ozempic became a household name over time and a social media topic of discussion for its weight loss ...